Abecma Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - Æxlishemjandi lyf - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Serevent Innúðalyf, dreifa 25 míkróg/skammt Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

serevent innúðalyf, dreifa 25 míkróg/skammt

glaxosmithkline pharma a/s - salmeterolum xínafóat - innúðalyf, dreifa - 25 míkróg/skammt

Livopan Lyfjagas undir þrýstingi 50/50 % Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

livopan lyfjagas undir þrýstingi 50/50 %

linde sverige ab - dinitrogenii oxidum; oxygenium - lyfjagas undir þrýstingi - 50/50 %

Atomoxetin Actavis Hart hylki 10 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

atomoxetin actavis hart hylki 10 mg

actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 10 mg

Atomoxetin Actavis Hart hylki 18 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

atomoxetin actavis hart hylki 18 mg

actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 18 mg

Atomoxetin Actavis Hart hylki 25 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

atomoxetin actavis hart hylki 25 mg

actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 25 mg

Atomoxetin Actavis Hart hylki 40 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

atomoxetin actavis hart hylki 40 mg

actavis group ptc ehf. - atomoxetinum hýdróklóríð - hart hylki - 40 mg